By Sino Biological Therapeutic monoclonal antibodies have emerged as the fastest-growing class of therapeutics since the mid-1980s from the increasing number of pharmaceutical companies seeking more drug modalities to extend their pipelines. Additionally, biosimilars now have more opportunities to enter the market as patents of some blockbuster monoclonal antibodies begin to expire. Given this context,…
Nordson Medical – Biopharmaceutical Components Cryogenic Compatibility
As we have seen with certain vaccines over the last 18 months, cryogenic transport and storage is becoming a significant issue for biopharmaceutical manufacturers as more products and components must be stored at very low temperatures to be kept functional. The repercussions of these new requirements are being felt throughout the biopharmaceutical production industry as…
Noble expands its services for its clients into Human Factors
Human Factors + (HF+) is a natural extension of Noble’s deep understanding of the patient experience relative to self-administering drug therapies By Tim McLeroy, Executive Director of Marketing & Patient Services The global market for medical devices is approximately $436 billion, bolstered by an aging population, according to data from hfMEDIC, the University of Utah-led…
Pharmaceutical Processing: May/June 2019 Issue
The May/June 2019 issue takes a look at: INTERPHEX Wrap-Up Self-Delivering RNAi (sd-rxRNA) How Technology Can Assist Biotech Research and Data Capturing Beyond Logistics: Exploring the Distributor’s Role in Bringing Innovative Drugs to Market Lasers Could Save Notre-Dame Cathedral Creating a Fully Fitted Out Cleanroom Controlled Environments’ Trends and Salary Survey Choosing Cleanroom Doors Jump into cGMP:…
Pharmaceutical Processing: March/April 2019 Issue
The March/April 2019 issue takes a look at: Pharma Execs Face the Feds Four Air Cargo Trends Shaping the Transport of Pharmaceuticals Scalable Viral Vector Manufacturing Advances in Vial Processing in Pharmaceutical Primary Packaging to Reduce Risk of Vial Damage and Particle Contamination Converting to a “Batch-less” World: Quality Implications of Continuous Manufacturing New Friends for…
Pharmaceutical Processing: January/February 2019 Issue
The January/February 2019 issue takes a look at: The Rapid Rise of Modular Construction Manufacturing Amorphous SDDs for Compounds Prone to Crystallization Pharma Facility Upgrades Understanding the FDA’s Priority Review Voucher System A Planner’s Guide to Filtered Fume Hoods What You Need to Know about Cleanroom Attire The Critical Link Between Particle Monitoring Systems and Business Continuity…
Nephron Pharmaceuticals Releases Opioid-Free Pain Management Med
The Nephron Pharmaceuticals Corp. 503B Outsourcing Facility launched a new opioid-free pain management product in response to the current crisis in America. The product, BKK, is a multimodal analgesia containing Bupivacaine, Ketorolac, and Ketamine. BKK consists of three 20mL prefilled syringes in one pack. Bupivacaine, Ketorolac, and Ketamine are used together as a preventive analgesic to…
Pharmaceutical Processing: November/December 2018 Issue
The November/December 2018 issue takes a look at: Outlook 2019: Tech, Data, and Biotech Boom Six Key Considerations to Ensure Container Closure Integrity In Drug Discovery, It’s About Time Two-Way Cloud Connectivity Can Trigger Ultimate Optimization Savings Digitalization: An Unintended, But Welcome Consequence of Serialization
GE Healthcare Collaborates to Manufacture Single-Use Consumables in China
Next Generation of Biosimilars and Biobetters
For innovation companies, highly differentiated and technologically advanced biobetters offer the greatest potential to mitigate the risks associated with the introduction of biosimilars, as they can be approved before the patent expires and have blockbuster potential.